1 |
Chal J and Pourquie O (2017) Making muscle: skeletal myogenesis in vivo and in vitro. Development 144, 2104-2122
DOI
|
2 |
Asfour HA, Allouh MZ and Said RS (2018) Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery. Exp Biol Med (Maywood) 243, 118-128
DOI
|
3 |
Benarroch L, Bonne G, Rivier F and Hamroun D (2019) The 2020 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disord 29, 980-1018
DOI
|
4 |
Akhmedov D and Berdeaux R (2013) The effects of obesity on skeletal muscle regeneration. Front Physiol 4, 371
DOI
|
5 |
Chang YC, Liu HW, Chen YT, Chen YA, Chen YJ and Chang SJ (2018) Resveratrol protects muscle cells against palmitate-induced cellular senescence and insulin resistance through ameliorating autophagic flux. J Food Drug Anal 26, 1066-1074
DOI
|
6 |
Zhang G, Chen X, Lin L, Wen C and Rao S (2012) [Effects of fatty acids on proliferation and differentiation of myoblast]. Wei Sheng Yan Jiu 41, 883-888
|
7 |
Saini A, Sharples AP, Al-Shanti N and Stewart CE (2017) Omega-3 fatty acid EPA improves regenerative capacity of mouse skeletal muscle cells exposed to saturated fat and inflammation. Biogerontology 18, 109-129
DOI
|
8 |
Xu D, Jiang Z, Sun Z et al (2019) Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetes. J Cell Physiol 234, 7510-7523
DOI
|
9 |
Mok GF, Lozano-Velasco E and Münsterberg A (2017) microRNAs in skeletal muscle development. Semin Cell Dev Biol 72, 67-76
DOI
|
10 |
Saliminejad K, Khorram Khorshid HR, Soleymani Fard S and Ghaffari SH (2019) An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol 234, 5451-5465
DOI
|
11 |
Ji C and Guo X (2019) The clinical potential of circulating microRNAs in obesity. Nat Rev Endocrinol 15, 731-743
DOI
|
12 |
Ortiz-Dosal A, Rodil-Garcia P and Salazar-Olivo LA (2019) Circulating microRNAs in human obesity: a systematic review. Biomarkers 24, 499-509
DOI
|
13 |
Kadrmas JL and Beckerle MC (2004) The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5, 920-931
DOI
|
14 |
Wei X and Zhang H (2020) Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression. Cancer Biol Med 17, 270-281
DOI
|
15 |
Windpassinger C, Schoser B, Straub V et al (2008) An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 82, 88-99
DOI
|
16 |
Chen DH, Raskind WH, Parson WW et al (2010) A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci 296, 22-29
DOI
|
17 |
Gueneau L, Bertrand AT, Jais JP et al (2009) Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 85, 338-353
DOI
|
18 |
Lee JY, Chien IC, Lin WY et al (2012) Fhl1 as a downstream target of Wnt signaling to promote myogenesis of C2C12 cells. Mol Cell Biochem 365, 251-262
DOI
|
19 |
Krol J, Loedige I and Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11, 597-610
DOI
|
20 |
Cowling BS, McGrath MJ, Nguyen MA et al (2008) Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. J Cell Biol 183, 1033-1048
DOI
|
21 |
Domenighetti AA, Chu PH, Wu T et al (2014) Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice. Hum Mol Genet 23, 209-225
DOI
|
22 |
Ding J, Cong YF, Liu B, Miao J and Wang L (2018) Aberrant protein turn-over associated with myofibrillar disorganization in FHL1 knockout mice. Front Genet 9, 273
DOI
|
23 |
Abreu P, Leal-Cardoso JH, Ceccatto VM and Hirabara SM (2017) Regulation of muscle plasticity and trophism by fatty acids: A short review. Rev Assoc Med Bras (1992) 63, 148-155
DOI
|
24 |
Han S, Cui C, He H et al (2019) FHL1 regulates myoblast differentiation and autophagy through its interaction with LC3. J Cell Physiol 235, 4667-4678
DOI
|
25 |
Zhao Y, Chen M, Lian D et al (2019) Non-coding RNA regulates the myogenesis of skeletal muscle satellite cells, injury repair and diseases. Cells 8, 988
DOI
|
26 |
Dambal S, Shah M, Mihelich B and Nonn L (2015) The microRNA-183 cluster: the family that plays together stays together. Nucleic Acids Res 43, 7173-7188
DOI
|
27 |
Zhao X, Jia Y, Chen H, Yao H and Guo W (2019) Plasma-derived exosomal miR-183 associates with protein kinase activity and may serve as a novel predictive biomarker of myocardial ischemic injury. Exp Ther Med 18, 179-187
|
28 |
Shao X, Wang M, Wei X et al (2016) Peroxisome proliferator-activated receptor-gamma: master regulator of adipogenesis and obesity. Curr Stem Cell Res Ther 11, 282-289
DOI
|
29 |
Lefterova MI, Zhang Y, Steger DJ et al (2008) PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22, 2941-2952
DOI
|
30 |
John E, Wienecke-Baldacchino A, Liivrand M, Heinaniemi M, Carlberg C and Sinkkonen L (2012) Dataset integration identifies transcriptional regulation of microRNA genes by PPARgamma in differentiating mouse 3T3-L1 adipocytes. Nucleic Acids Res 40, 4446-4460
DOI
|
31 |
Feng Y, Hang W, Sang Z et al (2019) Identification of exosomal and nonexosomal microRNAs associated with the drug resistance of ovarian cancer. Mol Med Rep 19, 3376-3392
|
32 |
Yang WM, Min KH and Lee W (2016) MicroRNA expression analysis in the liver of high fat diet-induced obese mice. Data Brief 9, 1155-1159
DOI
|